Literature DB >> 25546477

Benefits of fresh-frozen plasma as a replacement fluid to neutralize ABO antibodies.

Dong Il Won1, Ji Yeon Ham1, Chan Duck Kim2, Jang Soo Suh1, Byung Chang Kim3.   

Abstract

BACKGROUND: ABO-incompatible organ transplantation requires pre-transplant conditioning to reduce ABO antibody levels in the recipients. With respect to replacement fluids used in plasma exchange, we intended to verify whether fresh-frozen plasma (FFP) containing soluble ABO substance (SAS) is more effective than albumin solution in reducing ABO IgG antibody levels.
METHODS: Apheresis data were retrospectively studied for in vivo effects, and in vitro plasma mixing studies were prospectively performed. The amount of ABO IgG antibodies bound to red cells was measured as the mean fluorescence intensity (MFI) using flow cytometry. Neutralization of ABO antibodies in the recipientst plasma by an ABO-incompatible donornc plasma was measured using the inhibition assay principle. The MFI value of the unneutralized control tube was divided by that of the neutralized test tube (neutralizing-capacity index, NCI).
RESULTS: The plasma exchange procedures replaced with group AB FFP showed a significantly greater decreased titer than those replaced with albumin (P = 0.010). The in vitro plasma mixing study simulating plasma exchange also produced consistent results. When the pooled group O plasma was neutralized for anti-A by individual group AB plasmas (AB-to-O, N = 30), the NCI was 12.8 ± 5.4 (6.5-29.5). When this group O plasma was neutralized by pooled group AB or A plasma, the repeatedly measured NCI (N = 5) of A-to-O (11.4 ± 1.4) was not significantly different from that of AB-to-O (9.7 ± 1.3, P = 0.074).
CONCLUSIONS: ABO antibody levels are reduced more effectively by group AB FFP than by albumin. Either group AB or donor type (group A or B) FFP can be infused to group O recipients. FFP units with higher SAS levels can be selected from multiple available candidate units using our protocol for measuring the neutralizing-capacity.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ABO substance; flow cytometry; fresh-frozen plasma; plasma exchange

Mesh:

Substances:

Year:  2014        PMID: 25546477     DOI: 10.1002/jca.21378

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  2 in total

1.  Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum.

Authors:  Dong Il Won; Nan Young Lee; Jeong-Hoon Lim; Young Seok Han; Chan-Duck Kim; Seung Huh
Journal:  Blood Res       Date:  2020-06-30

2.  Blood Supply and Demand in Korea: What is in Store for the Future?

Authors:  Juhye Roh; Seung Jun Choi; Sinyoung Kim; Hyukki Min; Hyun Ok Kim
Journal:  Yonsei Med J       Date:  2020-05       Impact factor: 2.759

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.